Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous mesenchymal stem cells + bone marrow mononuclear cells (Jianming Tan)
- Development stage
- Unknown
- Lead developer
- Jianming Tan
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Infusion
01
Overview
This experimental cell therapy combination consists of expanded autologous mesenchymal stem cells (MSCs) and bone marrow mononuclear cells (BMMNCs). Developed by Jianming Tan, the treatment is designed to address osteonecrosis of the femoral head (ONFH) by leveraging the immunosuppressive and tissue-repairing properties of MSCs alongside the revascularization potential of BMMNCs. The therapy involves the infusion of these cells into the affected area to promote bone regeneration and restore blood supply in patients with early-stage (ARCO phase I and II) disease.
- Other names
- mesenchymal stem cell infusionbone marrow mononuclear cell infusionMSC + BMMNC therapy
Beyond the preview
Go deeper on autologous mesenchymal stem cells + bone marrow mononuclear cells (Jianming Tan).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous mesenchymal stem cells + bone marrow mononuclear cells (Jianming Tan).